Literature DB >> 22692949

The epidemiology of hepatoblastoma.

Logan G Spector1, Jill Birch.   

Abstract

Few causes of hepatoblastoma have been conclusively identified, mainly due to the extreme rarity of the disease. Inherited conditions including Familial Adenomatous Polyposis and Beckwith-Wiedemann Syndrome dramatically raise risk of hepatoblastoma but account for few cases overall. A small number of case-control studies investigating risk factors for sporadic hepatoblastoma have been conducted to date. Although most of these studies feature fewer than 200 cases, several clues have emerged. Most notably there is a roughly 20-fold increased risk of hepatoblastoma among children with very low birth weight (<1,500 g) and a doubling of risk among those with moderately low birth weight (1,500-2,500 g). A modicum of evidence points to a possible role of parental tobacco use prior to or during pregnancy in the causation of hepatoblastoma as well.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22692949     DOI: 10.1002/pbc.24215

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  78 in total

1.  A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT).

Authors:  Eiso Hiyama; Yuka Ueda; Yoshiyuki Onitake; Shou Kurihara; Kenichiro Watanabe; Tomoro Hishiki; Tatsuro Tajiri; Komei Ida; Michihiro Yano; Satoshi Kondo; Takaharu Oue
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

2.  Development of the Serum α-Fetoprotein Reference Range in Patients with Beckwith-Wiedemann Spectrum.

Authors:  Kelly A Duffy; Jennifer L Cohen; Okan U Elci; Jennifer M Kalish
Journal:  J Pediatr       Date:  2019-06-22       Impact factor: 4.406

3.  American College of Radiology LI-RADS in pediatric patients: the good, the bad, and the future.

Authors:  Gary R Schooler
Journal:  Pediatr Radiol       Date:  2019-05-08

Review 4.  Imaging of solid congenital abdominal masses: a review of the literature and practical approach to image interpretation.

Authors:  Krista L Birkemeier
Journal:  Pediatr Radiol       Date:  2020-11-30

5.  Utility of PAS and β-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas.

Authors:  Goutam Bera; Ram Narayan Das; Paromita Roy; Ranajoy Ghosh; Nelofar Islam; Prafulla Kumar Mishra; Uttara Chatterjee
Journal:  Pediatr Surg Int       Date:  2017-06-19       Impact factor: 1.827

6.  Defining an optimal time window to screen for hepatoblastoma in children with Beckwith-Wiedemann syndrome.

Authors:  Alessandro Mussa; Kelly A Duffy; Diana Carli; Giovanni Battista Ferrero; Jennifer M Kalish
Journal:  Pediatr Blood Cancer       Date:  2018-09-30       Impact factor: 3.167

Review 7.  Children's Oncology Group's 2013 blueprint for research: epidemiology.

Authors:  Logan G Spector; Julie A Ross; Andrew F Olshan
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

Review 8.  Children's Oncology Group's 2013 blueprint for research: rare tumors.

Authors:  Carlos Rodriguez-Galindo; Mark Krailo; Lindsay Frazier; Murali Chintagumpala; James Amatruda; Howard Katzenstein; Marcio Malogolowkin; Logan Spector; Farzana Pashankar; Rebecka Meyers; Gail Tomlinson
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

Review 9.  Cancer of childhood in sub-Saharan Africa.

Authors:  Cristina Stefan; Freddie Bray; Jacques Ferlay; Biying Liu; D Maxwell Parkin
Journal:  Ecancermedicalscience       Date:  2017-07-28

10.  Genomic Profiling Reveals Unique Molecular Alterations in Hepatoblastomas and Adjacent Hepatocellular Carcinomas in B6C3F1 Mice.

Authors:  Sachin Bhusari; Arun R Pandiri; Hiroaki Nagai; Yu Wang; Julie Foley; Hue-Hua L Hong; Thai-Vu Ton; Michael DeVito; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; David E Malarkey; Michelle J Hooth; Robert C Sills; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2015-08-18       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.